Introduction of an innovative system for referral of patients for clinical trials

With the current project proposal, SMO BULGARIA LTD is aiming to develop and put on the market innovative service - Sendpatient for the purpose of assisting in carrying out clinical studies. Project Introduction of an innovative system for referral of patients for clinical trials is dedicated to the resolution of current questions and the removal of obstacles that are common for this kind of studies. In order to accomplish its goals and to be helpful to the society, the sphere of clinical studies needs to have enough patients for clinical studies and precisely the lacking numbers of patients are a major problem. The above mentioned is becoming a challenge difficult to overcome in the face of the pharmacy and also for the implementation of innovative treatments. Sendpatient presents innovative services with global coverage, which will be realized by a combination of online-based system – sendpatient.com, necessary hardware and a team to promote the product. The innovative nature of the product can be characterized with the following: - Innovative and unused service for the recruitment of patients for clinical studies; -Global online-based system, which will include basic information about every Study with low number of patients; information about the general characteristics that the patients must have in order to join a clinical study; accessibility for all potential referencing doctors; -Beneficial effect for all the participants in the process: the patients, doctors and pharmacy companies. The huge interest in recruiting patients for clinical studies, the lack of offering (or none of it) of products, that can mediate the process of recruiting patients and the innovative plan for SENDPATIENT predisposes the success of the market realization on this original and innovative service. That will help SMO BULGARIA LTD to develop its innovative activity in the sphere of the Industry for Healthy living and Biotechnologies.

Comments
Leave a comment

Overview

Status Closed (completion date)
Start date 07 Jul, 2017
End date 02 Aug, 2019
Contract date 07 Jul, 2017
View in UMIS

Financial information

Total cost 993,800.00
Grant 695,660.00
Self finance 298,140.00
Total paid 614,250.00
EU participation percent 85.0%

Location